Waegemans T - Search Results

1

A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies.

Beliard R, Waegemans T, Notelet D, Massad L, Dhainaut F, Romeuf Cd, Guemas E, Haazen W, Bourel D, Teillaud JL, Prost JF. Beliard R, et al. Among authors: waegemans t. Br J Haematol. 2008 Apr;141(1):109-19. doi: 10.1111/j.1365-2141.2008.06985.x. Epub 2008 Feb 12. Br J Haematol. 2008. PMID: 18279459 Free article. Clinical Trial.

2

[Comparative study of hospital costs associated with human albumin 20% (Vialebex 20%) or polygeline as a fluid resuscitation strategy for cirrhotic ascites].

Durand-Zaleski I, Alberti C, Guemas E, Golly D, Padrazzi B, Waegemans T. Durand-Zaleski I, et al. Among authors: waegemans t. Presse Med. 2007 Jun;36(6 Pt 1):867-73. doi: 10.1016/j.lpm.2007.02.003. Epub 2007 Mar 26. Presse Med. 2007. PMID: 17379475 Clinical Trial. French.

3

Auto-antibodies in multiple sclerosis: an hypothesis.

Waegemans T. Waegemans T. Biomed Pharmacother. 2004 Jun;58(5):282-5. doi: 10.1016/j.biopha.2004.04.003. Biomed Pharmacother. 2004. PMID: 15194163 Review. No abstract available.

4

Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate.

Négrier C, Rothschild C, Goudemand J, Borg JY, Claeyssens S, Alessi MC, Jaffry AC, Teboul C, Padrazzi B, Waegemans T. Négrier C, et al. Among authors: waegemans t. J Thromb Haemost. 2008 Sep;6(9):1494-9. doi: 10.1111/j.1538-7836.2008.03076.x. Epub 2008 Jul 9. J Thromb Haemost. 2008. PMID: 18627444 Free article.

5

[Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].

Cortey A, Elzaabi M, Waegemans T, Roch B, Aujard Y. Cortey A, et al. Among authors: waegemans t. Arch Pediatr. 2014 Sep;21(9):976-83. doi: 10.1016/j.arcped.2014.02.005. Epub 2014 Aug 11. Arch Pediatr. 2014. PMID: 25125032 Review. French.

6

Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients.

Léger JM, Viala K, Cancalon F, Maisonobe T, Gruwez B, Waegemans T, Bouche P. Léger JM, et al. Among authors: waegemans t. J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):93-6. doi: 10.1136/jnnp.2007.121756. J Neurol Neurosurg Psychiatry. 2008. PMID: 18079302

7

Clinical efficacy of piracetam in cognitive impairment: a meta-analysis.

Waegemans T, Wilsher CR, Danniau A, Ferris SH, Kurz A, Winblad B. Waegemans T, et al. Dement Geriatr Cogn Disord. 2002;13(4):217-24. doi: 10.1159/000057700. Dement Geriatr Cogn Disord. 2002. PMID: 12006732

8

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

Betts T, Waegemans T, Crawford P. Betts T, et al. Among authors: waegemans t. Seizure. 2000 Mar;9(2):80-7. doi: 10.1053/seiz.2000.0380. Seizure. 2000. PMID: 10845730 Free article. Clinical Trial.

9

Effectiveness of piracetam in cortical myoclonus.

Brown P, Steiger MJ, Thompson PD, Rothwell JC, Day BL, Salama M, Waegemans T, Marsden CD. Brown P, et al. Among authors: waegemans t. Mov Disord. 1993;8(1):63-8. doi: 10.1002/mds.870080112. Mov Disord. 1993. PMID: 8419809 Clinical Trial.

10

Measurement of reaction times in tasks of varying complexity: an indication of the degree and evolution of mental deterioration in the elderly.

Waegemans T. Waegemans T. Pharmatherapeutica. 1986;4(8):510-24. Pharmatherapeutica. 1986. PMID: 3012588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page